A glimpse at Checkpoint Therapeutics Inc.’s potential climb to old highs

In the latest session, Checkpoint Therapeutics Inc. (NASDAQ: CKPT) closed at $0.63 down -7.90% from its previous closing price of $0.68. In other words, the price has decreased by -$0.0537 from its previous closing price. On the day, 484697 shares were traded. CKPT stock price reached its highest trading level at $0.6700 during the session, while it also had its lowest trading level at $0.6105.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



For a deeper understanding of Checkpoint Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90.

Upgrades & Downgrades

On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.

On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 23 when Oliviero James F III sold 15,000 shares for $1.11 per share. The transaction valued at 16,650 led to the insider holds 2,562,003 shares of the business.

Oliviero James F III sold 12,000 shares of CKPT for $13,080 on Jun 22. The CEO, President and Director now owns 2,577,003 shares after completing the transaction at $1.09 per share. On Jun 21, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 21,000 shares for $1.09 each. As a result, the insider received 22,890 and left with 2,589,003 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 522.61.

Stock Price History:

Over the past 52 weeks, CKPT has reached a high of $3.32, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 0.9521, while the 200-Day Moving Average is calculated to be 1.2968.

Shares Statistics:

For the past three months, CKPT has traded an average of 273.73K shares per day and 301.75k over the past ten days. A total of 88.57M shares are outstanding, with a floating share count of 65.44M. Insiders hold about 4.20% of the company’s shares, while institutions hold 13.60% stake in the company. Shares short for CKPT as of Oct 13, 2022 were 3.13M with a Short Ratio of 3.09M, compared to 3.17M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.38% and a Short% of Float of 4.38%.

Earnings Estimates

There are 3 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.15 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.16, while EPS last year was -$0.14. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.05 and low estimates of -$0.23.

Analysts are recommending an EPS of between -$0.62 and -$0.75 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.67, with 3 analysts recommending between -$0.62 and -$0.74.

Revenue Estimates

A total of 2 analysts have provided revenue estimates for CKPT’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $70k, resulting in an average revenue estimate of $80k. In the same quarter a year ago, actual revenue was $268k, down -70.10% from the average estimate.